CureGN: Cure Glomerulonephropathy Network
Investigator
what is the Cure-GN study?
CureGN has assembled nephrologists, scientists with broad expertise, private entities, and patients in a consortium to maintain and analyze a large, longitudinal observational data set. This broad effort provides a critical infrastructure that will advance our ability to study, classify, characterize, diagnose, and treat primary glomerular diseases of the kidney.
It is a multi-center consortium sponsored by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). It aims to work collaboratively to address major challenges to understanding the underlying biology of Minimal Change Disease, FSGS, MN, and IgAN. The goal is to recruit and maintain a large cohort of patients (2,400) with glomerular disease and follow them prospectively with standardized clinical data and bio-specimen collection. In April 2020 CureGN 2.0 launched, extending the study for an additional 5 years.
WHO DO I Contact FOR MORE INFORMATION?
Principal Investigator